drugset / Trial / NCT01757119

Ferrous Sulphate Supplement in Women With Iron Deficiency Anaemia

NCT01757119

Phase 1 Completed 55 enrolled Pierre Fabre Laboratories
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to investigate the pharmacokinetics of serum iron (the amount of iron in blood) after single oral administration of 2 tablets of L0008 80 mg (as ferrous sulphate) in women with iron deficiency anaemia.

Timeline

Start
2013-01
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferrous Sulfate Diagnostic / imaging agent 80 mg Oral